We are live on ! Find out more
LKFT

Lakefront Biotherapeutics American Depositary Shares
LKFT

83 hedge funds and large institutions have $595M invested in Lakefront Biotherapeutics American Depositary Shares in 2021 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 32 increasing their positions, 23 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

66% more call options, than puts

Call options by funds: $40.4M | Put options by funds: $24.3M

60% more funds holding in top 10

Funds holding in top 10: 5 → 8 (+3)

39% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 23

32% more capital invested

Capital invested by funds: $450M → $595M (+$145M)

27% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 15

3.42% more ownership

Funds ownership: 13.05% → 16.47% (+3.4%)

2% more funds holding

Funds holding: 81 → 83 (+2)

Holders
83
Holders Change
+2
Holders Change %
+2.47%
% of All Funds
1.28%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.12%
New
19
Increased
32
Reduced
23
Closed
15
Calls
$40.4M
Puts
$24.3M
Net Calls
+$16.1M
Net Calls Change
+$32.2M

Top Buyers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
+$34.7M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$33.7M
3
GPP
Great Point Partners
Connecticut
+$15.7M
4
6CM
683 Capital Management
New York
+$10.6M
5
GC
Greenlight Capital
New York
+$9.65M

Top Sellers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
-$12.8M
2
Parallax Volatility Advisers
Parallax Volatility Advisers
California
-$9.97M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$4.04M
4
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board
Ontario, Canada
-$3M
5
Morgan Stanley
Morgan Stanley
New York
-$2.14M
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$4.2M +$683K +13,100 +21%
BC
27
Brookfield Corp
Ontario, Canada
$3.68M +$3.49M +66,805 New
UBS Group
28
UBS Group
Switzerland
$3.65M +$3.41M +65,334 +7,527%
Renaissance Technologies
29
Renaissance Technologies
New York
$3.12M +$297K +5,700 +11%
Fidelity Investments
30
Fidelity Investments
Massachusetts
$2.73M -$1.97M -37,739 -43%
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
$2.72M -$4.04M -77,392 -61%
Voloridge Investment Management
32
Voloridge Investment Management
Florida
$2.7M -$1.99M -38,226 -44%
SSA
33
Schonfeld Strategic Advisors
New York
$2.39M +$2.27M +43,426 New
DCM
34
DAFNA Capital Management
California
$2.35M -$1.83M -35,000 -45%
CC
35
Carlson Capital
Texas
$2.21M +$2.09M +40,000 New
Bank of America
36
Bank of America
North Carolina
$2.15M +$1.58M +30,269 +346%
BCM
37
Bluefin Capital Management
New York
$2.1M +$1.27M +24,325 +177%
CSS
38
Cubist Systematic Strategies
Connecticut
$2.01M -$271K -5,189 -12%
ECM
39
ExodusPoint Capital Management
New York
$2M +$850K +16,294 +81%
Optiver Holding
40
Optiver Holding
Netherlands
$1.71M +$321K +6,149 +24%
AA
41
AlphaCentric Advisors
Puerto Rico
$1.71M +$78.3K +1,500 +5%
CM
42
Caption Management
Oklahoma
$1.65M +$1.57M +30,000 New
CCM
43
Cinctive Capital Management
New York
$1.55M +$1.47M +28,100 New
JGC
44
J. Goldman & Co
New York
$1.54M +$1.46M +27,972 New
Parallax Volatility Advisers
45
Parallax Volatility Advisers
California
$1.48M -$9.97M -191,124 -88%
AC
46
Apogem Capital
New York
$1.43M +$350K +6,711 +35%
FIM
47
Freedom Investment Management
Connecticut
$1.3M +$74.4K +1,426 +6%
PCM
48
Prelude Capital Management
New York
$1.24M +$1.17M +22,505 New
HT
49
HAP Trading
New York
$1.23M -$332K -6,361 -22%
AllianceBernstein
50
AllianceBernstein
Tennessee
$1.1M +$1.04M +20,000 New
1
2
3 4

LKFT Hedge Fund Activity: Q4 2021 in Review

83 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Lakefront Biotherapeutics American Depositary Shares (LKFT) for Q4 2021, worth a combined $595M — up 32% from $450M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new LKFT positions and 15 closed out — a net gain of 4 holders — while 32 added to existing stakes and 23 trimmed.

The largest buyer was EcoR1 Capital, adding an estimated $34.7M. The largest seller was Stonepine Capital Management, exiting entirely with an estimated $12.8M sold.

  • 83 institutional investors held Lakefront Biotherapeutics American Depositary Shares (LKFT) as of Q4 2021, up from 81 in Q3 2021.
  • Funds reported $595M of Lakefront Biotherapeutics American Depositary Shares stock for Q4 2021, up 32% quarter-over-quarter.
  • 19 funds opened new Lakefront Biotherapeutics American Depositary Shares positions in Q4 2021 and 15 closed out, a net change of +4 holders.
  • The largest Lakefront Biotherapeutics American Depositary Shares buyer in Q4 2021 was EcoR1 Capital, an estimated $34.7M added.
  • The largest Lakefront Biotherapeutics American Depositary Shares seller in Q4 2021 was Stonepine Capital Management, an estimated $12.8M sold.

Based on aggregated 13F filings for Q4 2021.